P-157A phase II study of XELOX and Cetuximab (Erbitux) as...

Annals of Oncology 2016 / 06 Vol. 27; Iss. suppl 2

P-157A phase II study of XELOX and Cetuximab (Erbitux) as first-line therapy in patients with KRAS wild-type metastatic colorectal cancer (FLEET2)

Iwamoto, S., Hazama, S., Kin, H., Takemoto, H., Kobayashi, K., Takahashi, Y., Kobayashi, M., Maeda, H., Nagata, N., Oba, K., Sakamoto, J., Mishima, H.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw199.151
Date:
June, 2016
File:
PDF, 65 KB
english, 2016
Conversion to is in progress
Conversion to is failed